Top Back to top

CAR-T cell treated patients registered in the EBMT Registry

by

EBMT centre members and national registries are requested to document CAR-T cell therapies

This is part of a long-term effort and commitment of EBMT, together with all interested stakeholders, to contribute to a full assessment of the medical value of this new category of medicinal products, including long-term safety and efficacy. Read the September News HERE

2. Number of CAR-T cell treated patients registered in the EBMT registry_November 2019

Countries reporting CAR-T cell treated patients to the EBMT registry_November 2019

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org